Coronary Revascularization clinical trials at UCLA

1 in progress, 0 open to eligible people

Showing trials for

  • EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction

    Sorry, in progress, not accepting new patients

    The primary objective of this study is to evaluate the effectiveness of early treatment with evolocumab plus routine lipid management vs routine lipid management alone when administered in the acute setting to reduce myocardial infarction, ischemic stroke, arterial revascularization, and all-cause death in subjects hospitalized for an acute myocardial infarction (non-ST-segment elevation myocardial infarction [NSTEMI] and ST-segment elevation myocardial infarction [STEMI]).

    Los Angeles, California and other locations

Our lead scientists for Coronary Revascularization research studies include .

Last updated: